Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026?
Health & MedicineOne-Off3moisManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 92.9%
Prévisionnistes
4
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 7 heures
Obsolète5 sept. 23, 09:52 UTC31 déc. 26, 22:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
When will Tesla Cybertruck be available in Europe?
Manifold MarketsWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill Drift0r's medical problem be found before 2027?
Manifold MarketsWhat will be true of the explosion at Harvard Medical School?
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiRègles
The clinical trials for fat tissue regrowing implants have already started in France and Spain.
- It is projected to finish in 2025.
- And it will change the silicon paradigm in plastic surgery.
- Will this technology be available for reconstructive or aesthetic breast surgery by the end of 2026 outside of clinical trials?
- https://www.theguardian.com/society/2022/jul/03/breast-reconstruction-cancer-silicone-implants-regrowing
- [link preview]
Marchés ouverts
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Volume total
- 15,7 M €
- Volume 24h
- 52,2 k €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 résultats de plus
- Volume total
- 870,4 k €
- Volume 24h
- 2,1 k €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volume total
- 922,5 k €
- Volume 24h
- 1,8 k €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 résultats de plus
- Volume total
- 32,4 k €
- Volume 24h
- 1,3 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Volume total
- 1,6 M €
- Volume 24h
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 résultats de plus
- Volume total
- 810,1 €
- Volume 24h
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? ?
- Manifold Markets cote No à 93% au 11 septembre 2026.
- Quand Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? sera-t-il résolu ?
- Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? doit être résolu le 31 décembre 2026.
- Comment Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? est-il réglé ?
- Manifold Markets règle ce marché comme suit : The clinical trials for fat tissue regrowing implants have already started in France and Spain.